4934 Stock Overview
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods.
Premier Anti-Aging Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||JP¥1,947.00|
|52 Week High||JP¥19,190.00|
|52 Week Low||JP¥1,777.00|
|1 Month Change||-48.97%|
|3 Month Change||-43.48%|
|1 Year Change||-86.66%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-62.99%|
Recent News & Updates
|4934||JP Personal Products||JP Market|
Return vs Industry: 4934 underperformed the JP Personal Products industry which returned -25.7% over the past year.
Return vs Market: 4934 underperformed the JP Market which returned -6.2% over the past year.
|4934 Average Weekly Movement||12.9%|
|Personal Products Industry Average Movement||4.7%|
|Market Average Movement||4.2%|
|10% most volatile stocks in JP Market||8.5%|
|10% least volatile stocks in JP Market||2.3%|
Stable Share Price: 4934 is more volatile than 90% of JP stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: 4934's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information.
Premier Anti-Aging Fundamentals Summary
|4934 fundamental statistics|
Is 4934 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4934 income statement (TTM)|
|Cost of Revenue||JP¥7.09b|
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
|Earnings per share (EPS)||136.23|
|Net Profit Margin||3.40%|
How did 4934 perform over the long term?See historical performance and comparison
Is 4934 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4934?
Other financial metrics that can be useful for relative valuation.
|What is 4934's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 4934's PE Ratio compare to its peers?
|4934 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
2927 AFC-HD AMS Life Science
4934 Premier Anti-Aging
Price-To-Earnings vs Peers: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the peer average (18.3x).
Price to Earnings Ratio vs Industry
How does 4934's PE Ratio compare vs other companies in the JP Personal Products Industry?
Price-To-Earnings vs Industry: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the JP Personal Products industry average (21x)
Price to Earnings Ratio vs Fair Ratio
What is 4934's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||14.3x|
|Fair PE Ratio||21.5x|
Price-To-Earnings vs Fair Ratio: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.5x).
Share Price vs Fair Value
What is the Fair Price of 4934 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4934 (¥1947) is trading below our estimate of fair value (¥3214.78)
Significantly Below Fair Value: 4934 is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: 4934 is poor value based on its PEG Ratio (1.1x)
Discover undervalued companies
How is Premier Anti-Aging forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4934's forecast earnings growth (12.7% per year) is above the savings rate (0.02%).
Earnings vs Market: 4934's earnings (12.7% per year) are forecast to grow faster than the JP market (9% per year).
High Growth Earnings: 4934's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4934's revenue (5.7% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 4934's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4934's Return on Equity is forecast to be low in 3 years time (17.6%).
Discover growth companies
How has Premier Anti-Aging performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical Household annual earnings growth
Earnings and Revenue History
Quality Earnings: 4934 has high quality earnings.
Growing Profit Margin: Insufficient data to determine if 4934's profit margins have improved over the past year.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 4934's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 4934's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: Insufficient data to determine if 4934's earnings growth over the past year exceeded the Personal Products industry average.
Return on Equity
High ROE: 4934's Return on Equity (14.6%) is considered low.
Discover strong past performing companies
How is Premier Anti-Aging's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4934's short term assets (¥11.9B) exceed its short term liabilities (¥4.2B).
Long Term Liabilities: 4934's short term assets (¥11.9B) exceed its long term liabilities (¥371.0M).
Debt to Equity History and Analysis
Debt Level: 4934 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 4934's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 4934's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4934's interest payments on its debt are well covered by EBIT (157.8x coverage).
Discover healthy companies
What is Premier Anti-Aging current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 4934's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4934's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 4934's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4934's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 4934 has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Kiyoshi Matsuura (53 yo)
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Premier Anti-Aging Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Premier Anti-Aging Co., Ltd.
- Ticker: 4934
- Exchange: TSE
- Founded: 2009
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: JP¥16.979b
- Shares outstanding: 8.72m
- Website: https://www.p-antiaging.co.jp
Number of Employees
- Premier Anti-Aging Co., Ltd.
- Toranomon Hills Mori Tower
- 8th Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.